Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sha Fu

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Immunity & Ageing : I & A|September 12, 2018
The baseline levels and risk factors for high-sensitive C-reactive protein in Chinese healthy populationYing Tang, Peifen Liang, Junzhe Chen, et al.
Frontiers in Immunology|October 17, 2022
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinomaXuanye Zhang, Yixin Zhou, Hualin Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2025
A Generative Foundation Model for Scalable Cytology Image Synthesis in AI-Powered DiagnosticsKe Zheng, Xueyi Zheng, Jue Wang, et al.
European Journal of Endocrinology|January 28, 2025
More than meets the eye: predicting adrenocortical carcinoma outcomes with pathomicsJianqiu Kong, Mingli Luo, Yi Huang, et al.
Cancer Medicine|January 20, 2020
Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinomaChen Chen, Yixin Zhou, Xuanye Zhang, et al.
BMC Nephrology|June 25, 2020
Systemic inflammation modulates the ability of serum ferritin to predict all-cause and cardiovascular mortality in peritoneal dialysis patientsSha Fu, Junzhe Chen, Bo Liu, et al.
JAMA Network Open|March 7, 2024
Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-AnalysisYixin Zhou, Anlin Li, Hui Yu, et al.
Journal of Translational Medicine|October 12, 2023
Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancerXing He, Yaorong Peng, Gui He, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|June 15, 2015
Ketamine promotes inflammation through increasing TLR4 expression in RAW264.7 cellsChen Meng, Zhen Liu, Gui-Lin Liu, et al.
Immunologic Research|November 26, 2022
[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancerLinfeng Luo, Anlin Li, Sha Fu, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Immunity & Ageing : I & A|September 12, 2018
The baseline levels and risk factors for high-sensitive C-reactive protein in Chinese healthy populationYing Tang, Peifen Liang, Junzhe Chen, et al.
Frontiers in Immunology|October 17, 2022
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinomaXuanye Zhang, Yixin Zhou, Hualin Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2025
A Generative Foundation Model for Scalable Cytology Image Synthesis in AI-Powered DiagnosticsKe Zheng, Xueyi Zheng, Jue Wang, et al.
European Journal of Endocrinology|January 28, 2025
More than meets the eye: predicting adrenocortical carcinoma outcomes with pathomicsJianqiu Kong, Mingli Luo, Yi Huang, et al.
Cancer Medicine|January 20, 2020
Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinomaChen Chen, Yixin Zhou, Xuanye Zhang, et al.
BMC Nephrology|June 25, 2020
Systemic inflammation modulates the ability of serum ferritin to predict all-cause and cardiovascular mortality in peritoneal dialysis patientsSha Fu, Junzhe Chen, Bo Liu, et al.
JAMA Network Open|March 7, 2024
Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-AnalysisYixin Zhou, Anlin Li, Hui Yu, et al.
Journal of Translational Medicine|October 12, 2023
Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancerXing He, Yaorong Peng, Gui He, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|June 15, 2015
Ketamine promotes inflammation through increasing TLR4 expression in RAW264.7 cellsChen Meng, Zhen Liu, Gui-Lin Liu, et al.
Immunologic Research|November 26, 2022
[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancerLinfeng Luo, Anlin Li, Sha Fu, et al.
Pageof 10